Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (5): 829-831. doi: 10.19723/j.issn.1671-167X.2022.05.008

Previous Articles     Next Articles

占国 栗*(),立敏 任   

  • Received:2022-06-10 Online:2022-10-18 Published:2022-10-14
  • Contact: 占国 栗 E-mail:li99@bjmu.edu.cn

RICH HTML

  

CLC Number: 

  • R593.2
1 Favero M , Belluzzi E , Ortolan A , et al. Erosive hand osteoarthritis: latest findings and outlook[J]. Nat Rev Rheumatol, 2022, 18 (3): 171- 183.
doi: 10.1038/s41584-021-00747-3
2 Cavasin F , Punzi F , Ramonda R , et al. Prevalence of erosive osteoarthritis of the hand in a population from Venetian area[J]. Reumatismo, 2004, 56 (1): 46- 50.
3 Kwok WY , Kloppenburg M , Marshall M , et al. Comparison of clinical burden between patients with erosive hand osteoarthritis and inflammatory arthritis in symptomatic community-dwelling adults: the Keele clinical assessment studies[J]. Rheumatology, 2013, 52 (12): 2260- 2267.
doi: 10.1093/rheumatology/ket267
4 Marshall M , Peat G , Nicholls E , et al. Subsets of symptomatic hand osteoarthritis in community-dwelling older adults in the United Kingdom: prevalence, inter-relationships, risk factor profiles and clinical characteristics at baseline and 3-years[J]. Osteoarthritis Cartilage, 2013, 21 (11): 1674- 1684.
doi: 10.1016/j.joca.2013.08.004
5 张晓盈, 郅新, 穆荣, 等. 侵蚀性手骨关节炎的临床及影像学特征分析[J]. 中华风湿病杂志, 2017, 21 (7): 455- 460.
6 Punzi L , Ramonda R , Sfriso P . Erosive osteoarthritis[J]. Best Pract Res Clin Rheumatol, 2004, 18 (5): 739- 758.
doi: 10.1016/j.berh.2004.05.010
7 Wittoek R , Cruyssen BV , Verbruggen G . Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis[J]. Arthritis Rheum, 2012, 64 (5): 1430- 1436.
doi: 10.1002/art.33502
8 Haugen IK , Mathiessen A , Slatkowsky-Christensen B , et al. Synovitis and radiographic progression in non-erosive and erosive hand osteoarthritis: is erosive hand osteoarthritis a separate inflammatory phenotype[J]. Osteoarthritis Cartilage, 2016, 24 (4): 647- 654.
doi: 10.1016/j.joca.2015.11.014
9 Gazeley DJ , Yeturi S , Patel PJ , et al. Erosive osteoarthritis: a systematic analysis of definitions used in the literature[J]. Semin Arthritis Rheum, 2017, 46 (4): 395- 403.
doi: 10.1016/j.semarthrit.2016.08.013
10 Stern AG , de Carvalho MRC , Buck GA , et al. Association of erosive hand osteoarthritis with a single nucleotide polymorphism on the gene encoding interleukin-1 beta[J]. Osteoarthritis Cartilage, 2003, 11 (6): 394- 402.
doi: 10.1016/S1063-4584(03)00054-2
11 Ramonda R , Musacchio E , Campana C , et al. Immunogenetic aspects of erosive osteoarthritis of the hand in patients from northern Italy[J]. Scand J Rheumatol, 2011, 40 (2): 139- 144.
doi: 10.3109/03009742.2010.507216
12 Kedor C , Detert J , Rau R , et al. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OATREAT study: a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial[J]. RMD Open, 2021, 7 (2): e001660.
doi: 10.1136/rmdopen-2021-001660
13 Ferrero S , Wittoek R , Allado E , et al. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial[J]. Semin Arthritis Rheum, 2021, 51 (4): 831- 838.
doi: 10.1016/j.semarthrit.2021.04.016
14 Favero M , Hoxha A , Frallonardo P , et al. Efficacy and safety of ultrasound-guided intra-articular glucocorticoid injection in erosive hand osteoarthritis[J]. Pain Med, 2021, 22 (5): 1229- 1232.
doi: 10.1093/pm/pnaa261
15 Aitken D , Laslett LL , Pan f , et al. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand osteoarthritis: the HUMOR trial[J]. Osteoarthritis Cartilage, 2018, 26 (7): 880- 887.
doi: 10.1016/j.joca.2018.02.899
16 Verbruggen G , Wittoek R , Vander-Cruyssen B , et al. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification[J]. Ann Rheum Dis, 2012, 71 (6): 891- 898.
doi: 10.1136/ard.2011.149849
17 Kloppenburg M , Ramonda R , Bobacz K , et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial[J]. Ann Rheum Dis, 2018, 77 (12): 1757- 1764.
doi: 10.1136/annrheumdis-2018-213202
18 Kloppenburg M , Peterfy C , Haugen IK , et al. Phase Ⅱ a, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis[J]. Ann Rheum Dis, 2019, 78 (3): 413- 420.
doi: 10.1136/annrheumdis-2018-213336
[1] Jiayi TIAN, Yixue GUO, Xia ZHANG, Xiaolin SUN, Jing HE. Flow cytometry analysis of normal range of natural killer cells and their subsets in peripheral blood of healthy Chinese adults [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 839-844.
[2] Yushu YANG, Xuan QI, Meng DING, Wei WANG, Huifang GUO, Lixia GAO. Diagnostic values of anti-salivary gland protein-1 antibody combined with anti-parotid secretory protein antibody for Sjögren's syndrome [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 845-852.
[3] Hua ZHONG, Yuan LI, Liling XU, Mingxin BAI, Yin SU. Application of 18F-FDG PET/CT in rheumatic diseases [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 853-859.
[4] Zhihui WU, Mingzhi HU, Qiaoying ZHAO, Fengfeng LV, Jingying ZHANG, Wei ZHANG, Yongfu WANG, Xiaolin SUN, Hui WANG. Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 860-867.
[5] Dongwu LIU, Jie CHEN, Mingli GAO, Jing YU. Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 928-931.
[6] Zhengfang LI,Cainan LUO,Lijun WU,Xue WU,Xinyan MENG,Xiaomei CHEN,Yamei SHI,Yan ZHONG. Application value of anti-carbamylated protein antibody in the diagnosis of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 729-734.
[7] 佳佳 乔,聪 田,晓波 黄,军 刘. [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 745-749.
[8] Huina HUANG,Jing ZHAO,Xiangge ZHAO,Ziran BAI,Xia LI,Guan WANG. Regulatory effect of lactate on peripheral blood CD4+ T cell subsets in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 519-525.
[9] Limin REN,Chuchu ZHAO,Yi ZHAO,Huiqiong ZHOU,Liyun ZHANG,Youlian WANG,Lingxun SHEN,Wenqiang FAN,Yang LI,Xiaomei LI,Jibo WANG,Yongjing CHENG,Jiajing PENG,Xiaozhen ZHAO,Miao SHAO,Ru Li. Low disease activity and remission status of systemic lupus erythematosus in a real-world study [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 273-278.
[10] Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283.
[11] Zhanhong LAI,Jiachen LI,Zelin YUN,Yonggang ZHANG,Hao ZHANG,Xiaoyan XING,Miao SHAO,Yuebo JIN,Naidi WANG,Yimin LI,Yuhui LI,Zhanguo LI. A unicenter real-world study of the correlation factors for complete clinical response in idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 284-292.
[12] Yi-jun HAN,Chang-hong LI,Xiu-ying CHEN,Jin-xia ZHAO. Comparison of clinical and immunological characteristics between primary Sjögren's syndrome patients with positive and negative anti-SSB antibody [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1000-1006.
[13] Jian-bin LI,Meng-na LYU,Qiang CHI,Yi-lin PENG,Peng-cheng LIU,Rui WU. Early prediction of severe COVID-19 in patients with Sjögren’s syndrome [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1007-1012.
[14] Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021.
[15] Wen-gen LI,Xiao-dong GU,Rui-qiang WENG,Su-dong LIU,Chao CHEN. Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1022-1027.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!